Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease.

Chen P, Li Y, Li L, Yu Q, Chao K, Zhou G, Qiu Y, Feng R, Huang S, He Y, Chen B, Chen M, Zeng Z, Zhang S.

Aliment Pharmacol Ther. 2019 Feb 7. doi: 10.1111/apt.15159. [Epub ahead of print]

PMID:
30734320
2.

A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.

Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.

Lancet Oncol. 2015 Jul;16(7):804-15. doi: 10.1016/S1470-2045(15)00048-0. Epub 2015 Jun 15.

PMID:
26088272
3.

Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.

Zahm AM, Hand NJ, Tsoucas DM, Le Guen CL, Baldassano RN, Friedman JR.

J Crohns Colitis. 2014 Sep;8(9):1108-17. doi: 10.1016/j.crohns.2014.02.012. Epub 2014 Mar 7.

4.

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease.

Wang H, Zhang S, Yu Q, Yang G, Guo J, Li M, Zeng Z, He Y, Chen B, Chen M.

Medicine (Baltimore). 2016 Feb;95(5):e2703. doi: 10.1097/MD.0000000000002703.

5.

A plasma microRNA signature as a biomarker for acquired aplastic anemia.

Hosokawa K, Kajigaya S, Feng X, Desierto MJ, Fernandez Ibanez MD, Rios O, Weinstein B, Scheinberg P, Townsley DM, Young NS.

Haematologica. 2017 Jan;102(1):69-78. doi: 10.3324/haematol.2016.151076. Epub 2016 Sep 22.

6.

Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases.

Schönauen K, Le N, von Arnim U, Schulz C, Malfertheiner P, Link A.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1547-1557. doi: 10.1093/ibd/izy046.

PMID:
29668922
7.

Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.

Miranda-García P, Chaparro M, Gisbert JP.

Gastroenterol Hepatol. 2016 Oct;39(8):508-15. doi: 10.1016/j.gastrohep.2016.01.015. Epub 2016 Mar 25.

PMID:
27020243
8.

Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.

Chen JM, Liu T, Gao S, Tong XD, Deng FH, Nie B.

World J Gastroenterol. 2017 Dec 14;23(46):8235-8247. doi: 10.3748/wjg.v23.i46.8235.

9.

RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke.

Tiedt S, Prestel M, Malik R, Schieferdecker N, Duering M, Kautzky V, Stoycheva I, Böck J, Northoff BH, Klein M, Dorn F, Krohn K, Teupser D, Liesz A, Plesnila N, Holdt LM, Dichgans M.

Circ Res. 2017 Sep 29;121(8):970-980. doi: 10.1161/CIRCRESAHA.117.311572. Epub 2017 Jul 19.

PMID:
28724745
10.

Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.

Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, You P, Li J, Dai Z, Liang X, Su Y, Hu Q, Wang F, Zhang ZY.

J Exp Clin Cancer Res. 2015 Aug 22;34:86. doi: 10.1186/s13046-015-0198-6.

11.

Circulating microRNAs as novel biomarkers of ALK-positive nonsmall cell lung cancer and predictors of response to crizotinib therapy.

Li LL, Qu LL, Fu HJ, Zheng XF, Tang CH, Li XY, Chen J, Wang WX, Yang SX, Wang L, Zhao GH, Lv PP, Zhang M, Lei YY, Qin HF, Wang H, Gao HJ, Liu XQ.

Oncotarget. 2017 Jul 11;8(28):45399-45414. doi: 10.18632/oncotarget.17535.

12.
13.

Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.

Oruç N, Ozütemiz O, Osmanoğlu N, Ilter T.

Turk J Gastroenterol. 2009 Mar;20(1):9-12.

14.

Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.

Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.

Tumour Biol. 2016 Jun;37(6):7777-84. doi: 10.1007/s13277-015-4608-3. Epub 2015 Dec 22.

PMID:
26695145
15.

A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.

Guo R, Fan G, Zhang J, Wu C, Du Y, Ye H, Li Z, Wang L, Zhang Z, Zhang L, Zhao Y, Lu Z.

J Alzheimers Dis. 2017;60(4):1365-1377. doi: 10.3233/JAD-170343.

PMID:
29036818
16.

MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.

Schaefer JS, Attumi T, Opekun AR, Abraham B, Hou J, Shelby H, Graham DY, Streckfus C, Klein JR.

BMC Immunol. 2015 Feb 10;16:5. doi: 10.1186/s12865-015-0069-0.

17.

Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1β, tumor necrosis factor-α, and interferon-γ.

Kutty RK, Nagineni CN, Samuel W, Vijayasarathy C, Jaworski C, Duncan T, Cameron JE, Flemington EK, Hooks JJ, Redmond TM.

Mol Vis. 2013 Apr 3;19:737-50. Print 2013.

18.

Integrated analysis of microRNA and mRNA expression profiles in the left atrium of patients with nonvalvular paroxysmal atrial fibrillation: Role of miR-146b-5p in atrial fibrosis.

Wang J, Wang Y, Han J, Li Y, Xie C, Xie L, Shi J, Zhang J, Yang B, Chen D, Meng X.

Heart Rhythm. 2015 May;12(5):1018-26. doi: 10.1016/j.hrthm.2015.01.026. Epub 2015 Jan 21.

PMID:
25617731
19.

Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.

Tan Y, Ge G, Pan T, Wen D, Gan J.

Clin Chim Acta. 2015 Dec 7;451(Pt B):232-9. doi: 10.1016/j.cca.2015.10.002. Epub 2015 Oct 17.

PMID:
26483130
20.

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.

Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.

Am J Gastroenterol. 2008 Jan;103(1):162-9. Epub 2007 Oct 4.

PMID:
17916108

Supplemental Content

Support Center